Global Information
회사소개 | 문의 | 비교리스트

세계의 골이식편 및 대체 골이식편 시장 예측(2020-2028년)

Global Bone Graft and Substitute Market Forecast 2020-2028

리서치사 Inkwood Research
발행일 2020년 02월 상품 코드 574465
페이지 정보 영문 233 Pages
가격
US $ 2,500 ₩ 2,954,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 되지 않으며, 인쇄 또한 불가능합니다.
US $ 3,000 ₩ 3,545,000 PDF (Multi User License) help
동일 사업장(소재지) 내 5명까지 이용가능한 라이센스입니다. PDF 파일은 Copy & Paste가 되지 않습니다. 인쇄는 1명당 1회에 한해 가능하며 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,500 ₩ 5,318,000 PDF (Enterprisewide License) help
동일 기업 및 100% 자회사의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 골이식편 및 대체 골이식편 시장 예측(2020-2028년) Global Bone Graft and Substitute Market Forecast 2020-2028
발행일 : 2020년 02월 페이지 정보 : 영문 233 Pages

세계 골이식편/대체 골이식편 시장 규모는 2020-2028년간 4.89%의 연평균 복합 성장률(CAGR)로 성장할 전망입니다. 시장 성장 주요인으로서 정형외과적 결함 증가, 세계 각국에서의 정형외과 수술 건수 증가, 최소침습술로의 전환, 인구 고령화의 급속한 진전 등을 들 수 있습니다. 특히, 건강하지 못한 생활습관이 확산되면서 비만이나 당뇨병 환자가 증가했고 그것이 시장 성장으로 연결되고 있습니다. 한편, 높은 수술 비용, 엄격한 규제, 윤리적 과제, 면역거부반응의 위험 등이 시장 성장에 방해가 될 가능성도 있습니다. 지역별로는 북미 국가가 가장 높은 점유율을 차지하고, 아시아태평양이 급성장을 이루고 있습니다.

세계의 골이식편 및 대체 골이식편(Bone Graft and Substitute) 시장을 분석했으며, 시장의 기본 구조, 주요 시장 성장 촉진요인 및 억제요인, 시장 규모 동향 전망(향후 9년간), 부문별/지역별 상세 동향, 시장 경쟁 동향, 주요 기업 개요(기업 개요, 주요 제품/서비스, 사업 전략 등) 등의 정보를 정리하여 전해드립니다.

제1장 조사 범위와 방법

제2장 개요

제3장 시장 역학

  • 시장 정의
  • 주요 시장 성장 촉진요인
    • 척추고정수술 및 관절재건수술 건수 증가
    • 건강에 좋지 않은 생활습관과 선택에 따른 퇴행성 관절질환 증가
    • 인구 고령화
    • 근골격계 장애를 수반한 치료 및 수술 증가
    • 생체 적합성이 있는 합성 골이식편 개발
    • 정형외과 시술 수요 증가
    • 기술 진보
  • 주요 시장 성장 억제요인
    • 골이식에 관련된 윤리적 문제
    • 높은 수술 비용
    • 엄격한 규제 승인 프로세스
    • 자가이식편 공급량의 제약과 기증자의 높은 이환율
    • 골이식편의 적용외 사용
    • 면역거부반응에 관한 외과적 위험

제4장 주요 분석

  • Porter's Five Forces 분석
  • 주요 구매 기준
  • 시장 기회 매트릭스
  • 벤더 상황
  • 주요 투자 인사이트

제5장 종류별 시장

  • 동종이식편
  • 자가이식편
  • 합성이식편 및 첨가물

제6장 용도별 시장

  • 척추 고정
  • 장골
  • 발 및 발목
  • 두개악안면
  • 관절 재건
  • 치과용 이식편

제7장 채취/고정 기기별 시장

  • 농축혈소판 혈장(PC) 시스템
  • 골수천자시스템
  • 천공기용 어태치먼트
  • 이식편 홀더
  • RIA 시스템
  • 기타

제8장 지역 분석

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 이탈리아
    • 러시아
    • 벨기에
    • 폴란드
    • 기타
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 호주 및 뉴질랜드
    • 한국
    • 태국
    • 인도네시아
    • 베트남
    • 기타
  • 기타 국가(RoW)
    • 라틴아메리카
    • 중동 및 아프리카

제9장 기업 개요

  • ALLOSOURCE, INC.
  • ARTHREX
  • BAXTER INTERNATIONAL INC.
  • BIOVENTUS LLC
  • DEPUY SYNTHES COMPANIES
  • INTEGRA LIFESCIENCES
  • MATHYS AG
  • MEDTRONIC INC.
  • NUVASIVE INC.
  • ORTHOFIX HOLDINGS, INC.
  • SIGMAGRAFT
  • SMITH & NEPHEW PLC
  • STRYKER CORPORATION
  • XTANT MEDICAL HOLDINGS, INC.
  • ZIMMER BIOMET HOLDINGS INC.
LSH 20.02.12

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - BONE GRAFT AND SUBSTITUTE
  • TABLE 2: GERIATRIC POPULATION ACROSS DIFFERENT REGION (60 YEARS & ABOVE)
  • TABLE 3: GLOBAL BONE GRAFT AND SUBSTITUTE, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 4: GLOBAL BONE GRAFT AND SUBSTITUTE, BY TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 5: GLOBAL ALLOGRAFTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 6: GLOBAL ALLOGRAFTS MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 7: GLOBAL AUTOGRAFT MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 8: GLOBAL AUTOGRAFT MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 9: GLOBAL SYNTHETICS AND ADDITIVES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 10: GLOBAL SYNTHETICS AND ADDITIVES MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 11: GLOBAL BONE GRAFT AND SUBSTITUTE MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 12: GLOBAL BONE GRAFT AND SUBSTITUTE MARKET, BY APPLICATION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 13: GLOBAL SPINAL FUSION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 14: GLOBAL SPINAL FUSION MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 15: GLOBAL LONG BONE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 16: GLOBAL LONG BONE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 17: GLOBAL FOOT AND ANKLE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 18: GLOBAL FOOT AND ANKLE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 19: GLOBAL CRANIOMAXILLOFACIAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 20: GLOBAL CRANIOMAXILLOFACIAL MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 21: GLOBAL JOINT RECONSTRUCTION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 22: GLOBAL JOINT RECONSTRUCTION MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 23: GLOBAL DENTAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 24: GLOBAL DENTAL MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 25: GLOBAL BONE GRAFT AND SUBSTITUTE MARKET, BY HARVESTING AND FIXATION DEVICES, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 26: GLOBAL BONE GRAFT AND SUBSTITUTE MARKET, BY HARVESTING AND FIXATION DEVICES, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 27: GLOBAL PLATELET CONCENTRATE SYSTEM MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 28: GLOBAL PLATELET CONCENTRATE SYSTEM MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 29: GLOBAL BONE MARROW ASPIRATE CONCENTRATE SYSTEMS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 30: GLOBAL BONE MARROW ASPIRATE CONCENTRATE SYSTEMS MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 31: GLOBAL TREPHINE ATTACHMENT TOOL MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 32: GLOBAL TREPHINE ATTACHMENT TOOL MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 33: GLOBAL IMPLANT HOLDER MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 34: GLOBAL IMPLANT HOLDER MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 35: GLOBAL SYNTHES RIA MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 36: GLOBAL SYNTHES RIA MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 37: GLOBAL OTHER HARVEST DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 38: GLOBAL OTHER HARVEST DEVICES MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 39: GLOBAL BONE GRAFT AND SUBSTITUTE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 40: GLOBAL BONE GRAFT AND SUBSTITUTE MARKET, BY REGION MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 41: NORTH AMERICA BONE GRAFT AND SUBSTITUTE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 42: NORTH AMERICA BONE GRAFT AND SUBSTITUTE MARKET, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 43: EUROPE BONE GRAFT AND SUBSTITUTE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 44: EUROPE BONE GRAFT AND SUBSTITUTE, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 45: ASIA PACIFIC BONE GRAFT AND SUBSTITUTE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 46: ASIA PACIFIC BONE GRAFT AND SUBSTITUTE MARKET, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 47: REST OF WORLD BONE GRAFT AND SUBSTITUTE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 48: REST OF WORLD BONE GRAFT AND SUBSTITUTE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

LIST OF FIGURES

  • FIGURE 1: RISING AGING POPULATION GLOBALLY 2016-2022 (MILLION)
  • FIGURE 2: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: KEY INVESTMENT INSIGHTS
  • FIGURE 6: GLOBAL BONE GRAFT AND SUBSTITUTE, BY TYPE, IN 2019
  • FIGURE 7: GLOBAL BONE GRAFT AND SUBSTITUTE MARKET, BY ALLOGRAFTS, 2020-2028 (IN $ MILLION)
  • FIGURE 8: GLOBAL BONE GRAFT AND SUBSTITUTE MARKET, BY AUTOGRAFT, 2020-2028 (IN $ MILLION)
  • FIGURE 9: GLOBAL BONE GRAFT AND SUBSTITUTE MARKET, BY SYNTHETICS AND ADDITIVES, 2020-2028 (IN $ MILLION)
  • FIGURE 10: GLOBAL BONE GRAFT AND SUBSTITUTE MARKET, BY APPLICATION, IN 2019
  • FIGURE 11: GLOBAL BONE GRAFT AND SUBSTITUTE MARKET, BY SPINAL FUSION, 2020-2028 (IN $ MILLION)
  • FIGURE 12: GLOBAL BONE GRAFT AND SUBSTITUTE MARKET, BY LONG BONE, 2020-2028 (IN $ MILLION)
  • FIGURE 13: GLOBAL BONE GRAFT AND SUBSTITUTE MARKET, BY FOOT AND ANKLE, 2020-2028 (IN $ MILLION)
  • FIGURE 14: GLOBAL BONE GRAFT AND SUBSTITUTE MARKET, BY CRANIOMAXILLOFACIAL, 2020-2028 (IN $ MILLION)
  • FIGURE 15: GLOBAL BONE GRAFT AND SUBSTITUTE MARKET, BY JOINT RECONSTRUCTION, 2020-2028 (IN $ MILLION)
  • FIGURE 16: GLOBAL BONE GRAFT AND SUBSTITUTE MARKET, BY DENTAL, 2020-2028 (IN $ MILLION)
  • FIGURE 17: GLOBAL BONE GRAFT AND SUBSTITUTE MARKET, BY HARVESTING AND FIXATION DEVICES, IN 2019
  • FIGURE 18: GLOBAL BONE GRAFT AND SUBSTITUTE MARKET, BY PLATELET CONCENTRATE SYSTEM, 2020-2028 (IN $ MILLION)
  • FIGURE 19: GLOBAL BONE GRAFT AND SUBSTITUTE MARKET, BY BONE MARROW ASPIRATE CONCENTRATE SYSTEMS, 2020-2028 (IN $ MILLION)
  • FIGURE 20: GLOBAL BONE GRAFT AND SUBSTITUTE MARKET, BY TREPHINE ATTACHMENT TOOL, 2020-2028 (IN $ MILLION)
  • FIGURE 21: GLOBAL BONE GRAFT AND SUBSTITUTE MARKET, BY IMPLANT HOLDER, 2020-2028 (IN $ MILLION)
  • FIGURE 22: GLOBAL BONE GRAFT AND SUBSTITUTE MARKET, BY SYNTHES RIA, 2020-2028 (IN $ MILLION)
  • FIGURE 23: GLOBAL BONE GRAFT AND SUBSTITUTE MARKET, BY OTHER HARVEST DEVICES, 2020-2028 (IN $ MILLION)
  • FIGURE 24: NORTH AMERICA BONE GRAFT AND SUBSTITUTE MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 25: THE UNITED STATES BONE GRAFT AND SUBSTITUTE MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 26: CANADA BONE GRAFT AND SUBSTITUTE MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 27: EUROPE BONE GRAFT AND SUBSTITUTE MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 28: THE UNITED KINGDOM BONE GRAFT AND SUBSTITUTE MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 29: FRANCE BONE GRAFT AND SUBSTITUTE MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 30: GERMANY BONE GRAFT AND SUBSTITUTE MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 31: ITALY BONE GRAFT AND SUBSTITUTE MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 32: RUSSIA BONE GRAFT AND SUBSTITUTE MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 33: BELGIUM BONE GRAFT AND SUBSTITUTE MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 34: POLAND BONE GRAFT AND SUBSTITUTE MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 35: REST OF EUROPE BONE GRAFT AND SUBSTITUTE MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 36: ASIA PACIFIC BONE GRAFT AND SUBSTITUTE MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 37: CHINA BONE GRAFT AND SUBSTITUTE MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 38: INDIA BONE GRAFT AND SUBSTITUTE MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 39: JAPAN BONE GRAFT AND SUBSTITUTE MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 40: AUSTRALIA & NEW ZEALAND BONE GRAFT AND SUBSTITUTE MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 41: SOUTH KOREA BONE GRAFT AND SUBSTITUTE MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 42: THAILAND BONE GRAFT AND SUBSTITUTE MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 43: INDONESIA BONE GRAFT AND SUBSTITUTE MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 44: VIETNAM BONE GRAFT AND SUBSTITUTE MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 45: REST OF ASIA PACIFIC BONE GRAFT AND SUBSTITUTE MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 46: REST OF WORLD BONE GRAFT AND SUBSTITUTE MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 47: LATIN AMERICA BONE GRAFT AND SUBSTITUTE MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 48: MIDDLE EAST & AFRICA BONE GRAFT AND SUBSTITUTE MARKET, 2020-2028 (IN $ MILLION)

KEY FINDINGS:

The global market of bone graft and substitute is estimated to grow at a CAGR of 4.89% during the estimated period of 2020-2028. The key factors propelling the market growth are the growing prevalence of orthopedic defects, rising orthopedic surgeries across the globe, a transition towards minimally invasive surgeries, and unprecedented growth of the aging population.

MARKET INSIGHTS:

The usage of bone graft and substitute is noted to the highest in spinal fusion surgeries, among other applications. However, in terms of revenue generation, the dental application is the largest segment. The major factors leading to the adoption of bone graft and substitute in dental surgeries are the flourishing tourism industry and comparatively low cost of the surgeries. The global market has been segmented based on application, type, and harvesting and fixation devices. The wide range of applications includes degenerative joint diseases, and spinal fusion and joint reconstruction. An unhealthy lifestyle leads to obesity and diabetes, which increases the risk of degenerative diseases. One of the common conditions of the aging population is osteoarthritis. Globally, one in twelve people above the age of 60 has osteoarthritis. The main reason for the adoption of bone graft and substitute in surgeries is these products are minimally invasive, thereby making the healing process faster with reduced pain in surgery.

The factors hampering the market growth are the high costs of the surgeries, strict regulations for the approval of orthobiological products due to off label use of bone graft material, ethical issues associated with bone grafting procedures, and surgical risk related to immune response.

REGIONAL INSIGHTS:

The global market of bone graft and substitute is analyzed geographically on the basis of markets situated across the regions of North America, Europe, Asia Pacific, and the Rest of the World. As of 2019, the region of North America holds the largest market share in terms of revenue and continues the trend by the end of the projected period. This is attributed to the rising incidences of bone fractures that require bone grafting treatment and other bone-related diseases like osteoporosis and osteoarthritis. The region of Asia Pacific is projected to be the fastest-growing market in terms of revenue. The rising demand for biocompatible synthetic bone grafts is one of the primary factors boosting the market growth in the region.

COMPETITIVE INSIGHTS:

The market boasts the presence of a large number of global industry players. Some of the prominent companies operating in the market are Baxter International Inc., Zimmer Biomet Holdings Inc., Integra LifeScience Corporation, Stryker Corporation, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Table of contents

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARIES

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. MARKET DEFINITION
  • 3.2. KEY DRIVERS
    • 3.2.1. RISE IN SPINAL FUSION AND JOINT RECONSTRUCTION
    • 3.2.2. UNHEALTHY LIFESTYLE CHOICES LEADING TO A RISE IN DEGENERATIVE JOINT DISEASES
    • 3.2.3. GROWING AGING POPULATION
    • 3.2.4. INCREASE IN TREATMENTS AND SURGERIES INVOLVING MUSCULOSKELETAL DISORDERS
    • 3.2.5. SURGING DEVELOPMENT OF BIOCOMPATIBLE SYNTHETIC BONE GRAFTS
    • 3.2.6. INCREASE IN DEMAND FOR ORTHOPEDIC PROCEDURE
    • 3.2.7. TECHNOLOGICAL ADVANCEMENTS
  • 3.3. KEY RESTRAINTS
    • 3.3.1. ETHICAL ISSUES ASSOCIATED WITH BONE GRAFTING PROCEDURES
    • 3.3.2. HIGH COST OF SURGERIES
    • 3.3.3. STRINGENT REGULATORY APPROVAL PROCESS
    • 3.3.4. LIMITED SUPPLY AND HIGH DONOR SITE MORBIDITY RATE FOR AUTOGRAPHS
    • 3.3.5. OFF-LABEL USE OF BONE GRAFT MATERIAL
    • 3.3.6. SURGICAL RISK RELATED TO REJECTION DUE TO IMMUNE RESPONSE

4. KEY ANALYTICS

  • 4.1. PORTER'S FIVE FORCE ANALYSIS
    • 4.1.1. THREAT OF NEW ENTRY
    • 4.1.2. THREAT OF SUBSTITUTION
    • 4.1.3. BUYER'S POWER
    • 4.1.4. SUPPLIER'S POWER
    • 4.1.5. COMPETITIVE RIVALRY
  • 4.2. KEY BUYING CRITERIA
  • 4.3. OPPORTUNITY MATRIX
  • 4.4. VENDOR LANDSCAPE
  • 4.5. KEY INVESTMENT INSIGHTS

5. MARKET BY TYPE

  • 5.1. ALLOGRAFTS
  • 5.2. AUTOGRAFT
  • 5.3. SYNTHETICS AND ADDITIVES

6. MARKET BY APPLICATION

  • 6.1. SPINAL FUSION
  • 6.2. LONG BONE
  • 6.3. FOOT AND ANKLE
  • 6.4. CRANIOMAXILLOFACIAL
  • 6.5. JOINT RECONSTRUCTION
  • 6.6. DENTAL

7. MARKET BY HARVESTING AND FIXATION DEVICES

  • 7.1. PLATELET CONCENTRATE SYSTEM
  • 7.2. BONE MARROW ASPIRATE CONCENTRATE SYSTEMS
  • 7.3. TREPHINE ATTACHMENT TOOL
  • 7.4. IMPLANT HOLDER
  • 7.5. SYNTHES RIA
  • 7.6. OTHER HARVEST DEVICES

8. GEOGRAPHICAL ANALYSIS

  • 8.1. NORTH AMERICA
    • 8.1.1. THE UNITED STATES
    • 8.1.2. CANADA
  • 8.2. EUROPE
    • 8.2.1. THE UNITED KINGDOM
    • 8.2.2. GERMANY
    • 8.2.3. FRANCE
    • 8.2.4. ITALY
    • 8.2.5. RUSSIA
    • 8.2.6. BELGIUM
    • 8.2.7. POLAND
    • 8.2.8. REST OF EUROPE
  • 8.3. ASIA PACIFIC
    • 8.3.1. CHINA
    • 8.3.2. INDIA
    • 8.3.3. JAPAN
    • 8.3.4. AUSTRALIA & NEW ZEALAND
    • 8.3.5. SOUTH KOREA
    • 8.3.6. THAILAND
    • 8.3.7. INDONESIA
    • 8.3.8. VIETNAM
    • 8.3.9. REST OF ASIA PACIFIC
  • 8.4. REST OF WORLD
    • 8.4.1. LATIN AMERICA
    • 8.4.2. MIDDLE EAST & AFRICA

9. COMPANY PROFILES

  • 9.1. ALLOSOURCE, INC.
  • 9.2. ARTHREX
  • 9.3. BAXTER INTERNATIONAL INC.
  • 9.4. BIOVENTUS LLC
  • 9.5. DEPUY SYNTHES COMPANIES
  • 9.6. INTEGRA LIFESCIENCES
  • 9.7. MATHYS AG
  • 9.8. MEDTRONIC INC.
  • 9.9. NUVASIVE INC.
  • 9.10. ORTHOFIX HOLDINGS, INC.
  • 9.11. SIGMAGRAFT
  • 9.12. SMITH & NEPHEW PLC
  • 9.13. STRYKER CORPORATION
  • 9.14. XTANT MEDICAL HOLDINGS, INC.
  • 9.15. ZIMMER BIOMET HOLDINGS INC.
Back to Top
전화 문의
F A Q